Cancer Prevention and Screening for People Living with Human Immunodeficiency Virus

Melody Wilkinson; Karen McCrea; Amy Culbertson

doi:10.1016/j.cnur.2024.01.002

Cancer Prevention and Screening for People Living with Human Immunodeficiency Virus

Nurs Clin North Am. 2024 Jun;59(2):273-288. doi: 10.1016/j.cnur.2024.01.002. Epub 2024 Mar 15.

Authors

Melody Wilkinson¹, Karen McCrea², Amy Culbertson²

Affiliations

¹ School of Nursing, Georgetown University, 3700 Reservoir Road, Washington, DC 20057, USA. Electronic address: mrw83@georgetown.edu.
² School of Nursing, Georgetown University, 3700 Reservoir Road, Washington, DC 20057, USA.

PMID: 38670694
DOI: 10.1016/j.cnur.2024.01.002

Abstract

People living with human immunodeficiency virus (HIV) (PLWH) live near-normal life expectancies due to advances in antiretroviral therapy. PLWH are experiencing more non-HIV-related comorbidities and deaths. PLWH are diagnosed with cancer more often and experience worse cancer-related outcomes than the general population. Cancer prevention and screening in PLWH is essential and leads to earlier diagnosis and treatment which may result in improved health outcomes and increased long-term survival. Few cancer screening guidelines specific to PLWH exist. There are often discrepancies in general population cancer screening guidelines. Familiarity with the utilization of cancer screening guidelines in this population is imperative.

Keywords: Cancer; Guidelines; Human immunodeficiency virus; Prevention; Screening.

Publication types

Review

MeSH terms

Early Detection of Cancer*
Female
HIV Infections* / diagnosis
HIV Infections* / prevention & control
Humans
Male
Mass Screening / standards
Neoplasms* / diagnosis
Neoplasms* / prevention & control